Atrial natriuretic peptide clearance inhibitors which resist degradation
US5449662A · kind A · utility
36Cited by
7References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 20, 1992 |
| Grant date | Sep 12, 1995 |
| Priority date | — |
| Expiry date | Feb 20, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds with natriuretic, diuretic and/or vasodilation activity which enhance the function of an endogenous ANP are provided. These compounds are capable of both binding to the clearance receptors for ANP and of inhibition of endopeptidase 24.11, an enzyme believed responsible for ANP clearance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.